Abstract
Previously, we have reported that inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channels by glibenclamide induced intracellular Ca2+ release from IP3‐sensitive stores and apoptosis in HepG2 human hepatoblastoma cells (Kim JA, Kang YS, Lee SH, Lee EH, Yoo BH, Lee YS. 1999 . Biochem Biophys Res Commun 261:682–688). In this study we investigated the upstream signals involved in the mechanism of these actions of glibenclamide. Treatment with glibenclamide initiated production of inositol 1,4,5‐trisphosphate (IP3) in a dose‐ and time‐dependent manner. The glibenclamide‐induced formation of IP3 was significantly inhibited by CFTR activators (levamisole and bromotetramisole). The intracellular Ca2+ release and apoptosis induced by glibenclamide were significantly suppressed by treatment with phospholipase C (PLC) inhibitors (U‐73122 and manoalide) or by pretreatment with pertussis toxin (PTx). In addition, PTx‐catalyzed ADP‐ribosylation of GTP‐binding proteins (G‐proteins) was markedly enhanced by treatment with glibenclamide in a time‐dependent manner. Taken together, these results suggest that PTx‐sensitive G‐proteins coupled to PLCβ may mediate the intracellular Ca2+ release and apoptosis induced by inhibiting CFTR Cl− channels in HepG2 cells. These results further suggest that the PTx‐sensitive G‐proteins may be a valuable target for the therapeutic intervention of human hepatomas. J. Cell. Biochem. 81:93–101, 2001.

This publication has 36 references indexed in Scilit: